Clinical Interaction

From GM-RKB
Jump to navigation Jump to search

A Clinical Interaction is a Statistical Interaction that evaluates the joint effects of 2 or more medical interventions or/and exposures.



References

2022a

  • (Wikipedia, 2022) ⇒ https://en.wikipedia.org/wiki/Interaction#Medicine_and_pharmacology Retrieved:2022-3-20.
    • In medicine, most medications can be safely used with other medicines, but particular combinations of medicines need to be monitored for interactions, often by the pharmacist. Interactions between medications fall generally into one of two main categories:
      • pharmacodynamic: Involving the actions of the two interacting drugs.
      • pharmacokinetic: Involving the absorption, distribution, metabolism, and excretion of one or both of the interacting drugs upon the other.
In terms of efficacy, there can be three types of interactions between medications: additive, synergistic, and antagonistic.
  • Additive interaction means the effect of two chemicals is equal to the sum of the effect of the two chemicals taken separately. This is usually due to the two chemicals acting on the body via same or similar mechanism. Examples are aspirin and motrin, alcohol and depressant, tranquilizer and painkiller.
  • Synergistic interaction means that the effect of two chemicals taken together is greater than the sum of their separate effect at the same doses. An example is pesticide and fertilizer.
  • Antagonistic interaction means that the effect of two chemicals is actually less than the sum of the effect of the two drugs taken independently of each other. This is because the second chemical increases the excretion of the first, or even directly blocks its toxic actions. Antagonism forms the basis for antidotes of poisonings.

2022b

  • (Wikipedia, 2022) ⇒ https://en.wikipedia.org/wiki/Glossary_of_clinical_research#I Retrieved:2022-3-20.
    • QUOTE: Interaction (Qualitative & Quantitative)
      • The situation in which a treatment contrast (e.g. difference between investigational product and control) is dependent on another factor (e.g. centre). A quantitative interaction refers to the case where the magnitude of the contrast differs at the different levels of the factor, whereas for a qualitative interaction the direction of the contrast differs for at least one level of the factor. (ICH E9)

2021

2017

Type of assessment Aim of the assessment
Effect modification Separate exposure effects according to another variable (...)
Interaction Evaluate individual and joint effects of exposures (...)
Mediation Evaluate direct and indirect effects of exposures (...)
Box 1: Main motivation for the assessment of effect modification, interaction and mediation.
The clinical motivation behind the assessment of effect modification is to identify whether the effect of a treatment (or exposure) is different in groups of patients with different characteristics. If the effects are the same, the treatment (or exposure) effect is called homogeneous; if the effects are different, they are called heterogeneous(...).

Assessing effect modification may also help to identify a subset of patients who would not benefit from an intervention at all(...).

Interaction is of interest when researchers want to obtain the joint effect of two (or more) exposures on a disease or outcome.[1] To be considered a synergistic interaction, the joint effect has to be higher than the effect expected by the sum of their individual effects. Conversely, there is an antagonistic interaction between exposures, when the joint effect is less than the sum of their individual effects. This is in contrast to effect modification, where the effect of an exposure on an outcome is assessed in different strata of a third variable, but a joint effect is not assessed.

From a clinical perspective, to assess interaction is particularly important when a disease can be treated by a combination of two or more treatments.

  1. Rothman KJ. Synergy and antagonism in cause-effect relationships. Am J Epidemiol. 1974;99(6):385–388.

2012

2009b